Curative Effect of EGFR-TKIs with Anti-angiogenic Drugs as the Treatment for Patients with Advanced EGFR-mutant Non-small Cell Lung Cancer：a Meta-analysis by LI Yong, LONG Yong, ZHAO Chong, ZHANG Guanqing, SU Yanhe

Subjects: “…|carcinoma, non-small-cell lung|angiogenesis inhibitors|epidermal growth factor receptor tyrosine kinase inhibitors|efficacy|meta-analysis…”
Get full text

LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein by Marker Daniel F, Puccini Jenna M, Mockus Taryn E, Barbieri Justin, Lu Shao-Ming, Gelbard Harris A

Subjects: “…Brain-specific angiogenesis inhibitor 1 (BAI1)…”
Get full text

Consecutive targeted therapy in patients with metastatic kidney cancer by А. S. Kalpinskiy, A. D. Kaprin, A. A. Kostin, K. M. Nyushko

Subjects: Get full text

Review of Therapeutic Strategies for Anaplastic Lymphoma Kinase-Rearranged Non-Small Cell Lung Cancer by Takafumi Fukui, Motoko Tachihara, Tatsuya Nagano, Kazuyuki Kobayashi

Subjects: Get full text

Trends and Challenges in Tumor Anti-Angiogenic Therapies by József Jászai, Mirko H.H. Schmidt

Subjects: Get full text

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review by Aloizio Premoli Maciel, Reyna Aguilar Quispe, Lázara Joyce Oliveira Martins, Rogério Jardim Caldas, Paulo Sérgio da Silva Santos

Subjects: Get full text

Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary) by Tatiana A. Staroverova

Subjects: “…angiogenesis inhibitors…”
Get full text

2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis. by Becker, C, Rohwer, N, Funakoshi, T, Cramer, T, Bernhardt, W, Birsner, A, Folkman, J, D'Amato, R

“…In conclusion, hypoxia appears to play an important role in the pathogenesis of endometriosis and endometriosis-associated angiogenesis, and the angiogenesis inhibitor 2-methoxyestradiol may be a potential candidate for systemic treatment in the future.…”

Сomparative Analysis of the Long-Term Results of Diabetic Macular Edema and Epiretinal Membrane Surgical Treatment by M. M. Bikbov, R. M. Zainullin, T. R. Gilmanshin, T. A. Khalimov

“…Patients were divided into 3 groups depending on the intravitreal use of an angiogenesis inhibitor. The analysis of the remote anatomical and functional results of patients of different groups during 1 year of observation was carried out. …”
Get full text

Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. by Hawighorst, T, Oura, H, Streit, M, Janes, L, Nguyen, L, Brown, L, Oliver, G, Jackson, D, Detmar, M

“…The roles played by the endogenous angiogenesis inhibitor thrombospondin-1 (TSP-1) in the early stages of multi-step carcinogenesis and in the control of hematogenous versus lymphatic metastasis are unknown. …”

In vitro study of liver tumor induced endothelial cell angiogenesis in microfluidic platform by Xie, Yufei

“…Subsequently, the successfully designed 3D micro-fluidic systems will be utilized to study the effect of angiogenesis inducing factors vessel-endothelial growth factor (VEGF) and tumor growth factor-beta (TGF-beta), anti-cancer drug (Taxol and angiogenesis inhibitor as well.…”
Get full text

Angiogenesis as a therapeutic target in arthritis in 2011: learning the lessons of the colorectal cancer experience. by Thairu, N, Kiriakidis, S, Dawson, P, Paleolog, E

“…The prototype targeted angiogenesis inhibitor anti-vascular endothelial growth factor (VEGF) antibody bevacizumab was approved in 2004 for colorectal cancer, and has since been approved for other cancers. …”

Myo/Nog Cells: The Jekylls and Hydes of the Lens by Jacquelyn Gerhart, Mindy George-Weinstein

“…Myo/Nog cells were discovered in the embryonic epiblast by their co-expression of the skeletal muscle-specific transcription factor MyoD, the bone morphogenetic protein inhibitor Noggin and brain-specific angiogenesis inhibitor 1. They were tracked from the epiblast into the developing lens, revealing heterogeneity of cell types within this structure. …”
Get full text

Differences in the regulation of Thrombospondin-1 expression between epithelial cells and fibroblasts by Rodriguez, Roberto Karlo

Get full text

A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies. by Xiaopan Wu, Jia Wu, Zhenhui Xin, Huifen Wang, Xilin Zhu, Liping Pan, Zhuo Li, Hui Li, Ying Liu

“…COL18A1 encodes the precursor of endostatin, which is a broad-spectrum angiogenesis inhibitor, and we speculate that SNPs in COL18A1 may be associated with susceptibility to HCC. …”
Get full text

Thalidomide-induced bronchiolitis obliterans organizing pneumonia in a patient with multiple myeloma by Zohra El Ati, Rais Lamia, Jouda Cherif, Hela Jbali, Lilia Ben Fatma, Ikram Mami, Rania Khedher, Wided Smaoui, Madiha Krid, Fethi Ben Hamida, Soumaya Beji, Mohamed Karim Zouaghi

“…Thalidomide, which is an angiogenesis inhibitor and immunomodulator that reduces tumor necrosis factor-alpha, has regained value in the treatment of multiple myeloma. …”
Get full text

Retinal Diseases: The Next Frontier in Pharmacodelivery by Assaf Ben-Arzi, Rita Ehrlich, Ron Neumann

“…Implants, new angiogenesis inhibitor agents, micro- and nano-carriers, and the anchored port delivery system are becoming new tools in this war. …”
Get full text

Effect of a coronary-heart-disease-associated variant of ADAMTS7 on endothelial cell angiogenesis by Pu, X, Chan, K, Yang, W

“…Proteomics analysis showed an increase in thrombospondin-1, a reported angiogenesis inhibitor, in culture media conditioned by ECs with ADAMTS7 knockdown and a decrease of thrombospondin-1 in media conditioned by ECs with ADAMTS7-Ser214 overexpression. …”

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis. by Becker, C, Beaudry, P, Funakoshi, T, Benny, O, Zaslavsky, A, Zurakowski, D, Folkman, J, D'Amato, R, Ryeom, S

“…Finally, treatment of endometriosis-bearing mice with the angiogenesis inhibitor Lodamin, an oral nontoxic formulation of TNP-470, significantly decreased EPC levels while suppressing lesion growth. …”

The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. by Gaballah, K, Oakley, R, Hills, A, Ryan, A, Partridge, M

“…METHODS: In this study, we evaluate the effect of the angiogenesis inhibitor, ZD4190, using a rodent model of residual carcinoma in deep tissues, mimicking the clinical scenario where low numbers of malignant cells persist at the operative site. …”